Name | | |
Last NAV | 95.04 | 81.74 |
Date of Valuation | 2025/09/17 | 2025/09/17 |
Sharpe Ratio | 0.76 | 0.00 |
3-Year Risk Return Ratio | 0.85 | 0.22 |
Cumulative Performance (%) |
| +11.12% | +10.79% |
| +17.33% | +22.29% |
| +40.99% | +10.83% |
| +59.49% | +34.00% |
| +14.80% | -23.40% |
| +6.50% | -20.20% |
| +8.60% | +41.30% |
| N/A | N/A |
Calendar Year Performance (%) |
| +14.80% | -23.40% |
| -29.90% | -25.80% |
| +6.50% | -20.20% |
| +39.40% | +69.40% |
| +8.60% | +41.30% |
3-Year Annualised Volatility | 18.49% | 25.88% |
Funds House | J.P. Morgan Asset Management | J.P. Morgan Asset Management |
Portfolio Manager | John Cho & Chun Yu Wong | Rebecca Jiang & Li Tan |
Funds Type | Equity Funds | Equity Funds |
Funds Size | USD 179000000 | USD 3876200000 |
Base Currency | USD | USD |
Sector | General | General |
Geographic Allocation | Korea | China |
Top Holdings |
| Samsung Electronics (9.80%) | Tencent (8.90%) |
| SK hynix (8.40%) | Meituan (6.40%) |
| LG Chem (3.60%) | Alibaba (7.30%) |
| Hyundai Motor (3.20%) | Pinduoduo (5.80%) |
| SAMSUNG C&T (3.20%) | China Pacific Insurance (2.80%) |
| NAVER (2.90%) | NetEase (3.00%) |
| SAMSUNG BIOLOGICS (4.60%) | Ping An Insurance (3.80%) |
| Samsung Electro-Mechanics (2.50%) | China Merchants Bank (3.10%) |
| Hana Financial Group (3.40%) | Trip.com (3.30%) |
| Shinhan Financial Group (2.80%) | Kweichow Moutai (2.60%) |
Minimum Initial Investment | USD 1000 | USD 1000 |
Initial Sales Fee | 5.0% of NAV | Currently 5.0% (up to 8.5% of NAV) |
Switching Fee | 1.0% of NAV | 1.0% of NAV |
Maintenance Fee | Trustee fee:0.03%–0.125% of NAV p.a. (maximum 0.2%; subject to the NAV and a minimum of USD 12,500 p.a.) | Trustee fee:0.4% of NAV p.a. |
Redemption Fee | 0.5% of NAV | Currently 0% (up to 1.0% of NAV) |
Launch Date | 1991/12/11 | 1994/07/04 |
End of Financial Year | 30/09 | 30/06 |
Country of Registry | Hong Kong | Luxembourg |
Other Relevant Information | | |
| |